[1] van der Weijden T, Boivin A, Burgers J, et al. Clinical practice guidelines and patient decision aids. An inevitable relationship [J]. J Clin Epidemiol, 2012, 65(6):584-589. [2] Graham R, Mancher M, Miller Wolman D, et al. editors. Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical practice guidelines we can trust[M]. Washington (DC): National Academies Press (US), 2011. [3] Qaseem A, Forland F, Macbeth F, et al. Guidelines international network: toward international standards for clinical practice guidelines [J]. Ann Intern Med, 2012, 156(7): 525-531. [4] 国家卫生健康委办公厅.国家卫生健康委办公厅关于印发口腔相关病种诊疗指南(2022年版)的通知[Z]. 2022. [5] Nothacker MJ, Muche-Borowski C, Kopp IB. Guidelines in the register of the association of scientific medical societies in germany-A quality improvement campaign [J]. Geburtshilfe Frauenheilkd, 2014, 74(3): 260-266. [6] German Association of the Scientific Medical Societies, Commission SG. AWMF guidance manual and rules for guideline development [Z]. 2012. [7] Hutchings A, Raine R. A systematic review of factors affecting the judgments produced by formal consensus development methods in health care [J]. J Health Serv Res Policy, 2006, 11(3): 172-179. [8] Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes [J]. J Clin Epidemiol, 2011, 64(4): 395-400. [9] Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias) [J]. J Clin Epidemiol, 2011, 64(4): 407-415. [10] Guyatt GH, Oxman AD, Montori V, et al. GRADE guidelines: 5. Rating the quality of evidence-publication bias [J]. J Clin Epidemiol, 2011, 64(12): 1277-1282. [11] Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the quality of evidence--imprecision [J]. J Clin Epidemiol, 2011, 64(12): 1283-1293. [12] Mlika-Cabanne N, Harbour R, de Beer H, et al. Sharing hard labour: developing a standard template for data summaries in guideline development [J]. BMJ Qual Saf, 2011, 20(2): 141-145. [13] Kirschneck C, Proff P, Lux C. Ideal treatment timing of orthodontic anomalies-a German clinical S3 practice guideline [J]. J Orofac Orthop, 2022, 83(4): 225-232. [14] Sanz M, Herrera D, Kebschull M, et al. Treatment of stage Ⅰ-Ⅲ periodontitis-The EFP S3 level clinical practice guideline [J]. J Clin Periodontol, 2020, 47 Suppl 22(Suppl 22): 4-60. [15] Rashid H, Lamberts A, Borradori L, et al. European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology-Part Ⅰ [J]. J Eur Acad Dermatol Venereol, 2021, 35(9): 1750-1764. [16] Schmidt E, Rashid H, Marzano AV, et al. European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology-Part Ⅱ [J]. J Eur Acad Dermatol Venereol, 2021, 35(10): 1926-1948. [17] Herrera D, Sanz M, Kebschull M, et al. Treatment of stage Ⅳ periodontitis: The EFP S3 level clinical practice guideline [J]. J Clin Periodontol, 2022, 49 Suppl 24: 4-71. [18] Herrera D, Berglundh T, Schwarz F, et al. Prevention and treatment of peri-implant diseases-The EFP S3 level clinical practice guideline [J]. J Clin Periodontol, 2023, 50 Suppl 26: 4-76. [19] Duncan HF, Kirkevang LL, Peters OA, et al. Treatment of pulpal and apical disease: The European Society of Endodontology (ESE) S3-level clinical practice guideline [J]. Int Endod J, 2023, 56 Suppl 3: 238-295. [20] Schünemann HJ, Wiercioch W, Brozek J, et al. GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT [J]. J Clin Epidemiol, 2017, 81: 101-110. [21] 王子君,姚亮,刘练,等.GRADE指南改编方法“ADOLOPMENT”介绍[J].中国循证医学杂志,2018,18(1):109-115. [22] West N, Chapple I, Claydon N, et al. BSP implementation of European S3-level evidence-based treatment guidelines for stage Ⅰ-Ⅲ periodontitis in UK clinical practice [J]. J Dent, 2021, 106: 103562. [23] Sanz M, Herrera D, Kebschull M, et al. Adopción/Adaptación para España de la Guía de Práctica Clínica de Nivel S3 de la Federación Europea de Periodoncia (EFP)-Tratamiento de la Periodontitis en Estadios Ⅰ-Ⅲ [J]. International Journal of Interdisciplinary Dentistry, 2022, 15(SPC): 60-109. [24] Kebschull M, Jepsen S, Kocher T, et al. Die Behandlung von Parodontitis Stadium Ⅰ bis Ⅲ [Z]. Die deutsche Implementierung der S3-Leitlinie "Treatment of Stage Ⅰ–Ⅲ Periodontitis " der European Federation of Periodontology (EFP) AWMF-Registernummer, 2020: 83-43. [25] Fervers B, Burgers JS, Haugh MC, et al. Adaptation of clinical guidelines: literature review and proposition for a framework and procedure [J]. Int J Qual Health Care, 2006, 18(3): 167-176. [26] 胡晶,陈茹,谢雁鸣,等.科学和规范的改编临床实践指南[J].中国循证儿科杂志,2012,7(3): 226-230. [27] 傅亮,胡雁,卢洪洲,等.艾滋病相关症状管理指南改编的方法及效果评价[J].中华护理杂志,2015,50(9): 1037-1042. [28] 王子君,周奇,邢丹,等.中国临床实践指南/共识解读类文献报告质量分析[J].协和医学杂志,2021,12(2): 260-267. [29] 陈斌,李艳芬,陈日新,等.欧洲牙周病学会Ⅳ期牙周炎治疗S3级临床指南解读[J].中华口腔医学杂志,2022,57(12): 1195-1201. [30] 邵金龙,于洋,吕春旭,等.欧洲牙周病学会牙周炎治疗S3级临床指南的介绍与应用解读[J].中华口腔医学杂志,2022,57(12): 1202-1208. [31] 曹正国,高雅,曾宇.基于2018年牙周病国际新分类的重度牙周炎临床应用实践[J].口腔医学研究,2023,39(11): 943-951. |